FDG-accumulating atherosclerotic plaques identified with 18F-FDG-PET/CT in 141 patients

Molecular Imaging and Biology

Volumn 11, Issue 6, 2009, Pages 455-459

  Wassélius, Johan A ^a,b   Larsson, Stig A ^b   Jacobsson, Hans ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Active plaque; Atherosclerosis; Cardiovascular risk factor; FDG PET CT; Imaging; Nuclear medicine; Radiology

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ABDOMINAL AORTA; AGED; ARTERY CALCIFICATION; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; FEMALE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL;

AGED; ATHEROSCLEROSIS; CALCINOSIS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 70350261795     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-009-0223-2     Document Type: Article

References (15)

1. Libby P (2002) Inflammation in atherosclerosis. Nature 420(6917):868-874
2. Davies MJ (1996) Stability and instability: Two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995. Circulation 94:2013-2020
3. Fishbein MC, Siegel RJ (1996) How big are coronary atherosclerotic plaques that rupture? Circulation 94(10):2662-2666
4. Libby P (2006) Atherosclerosis: Disease biology affecting the coronary vasculature. Am J Cardiol 98(12A):3Q-9Q
5. Bleeker-Rovers CP, Bredie SJ, van der Meer JW et al (2003) F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis. Neth J Med 61(10):323-329
6. Blockmans D, De Ceuninck L, Vanderschueren S et al (2007) Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: A prospective study in 35 patients. Rheumatology (Oxford) 46(4):672-677
7. Lederman RJ, Raylman RR, Fisher SJ et al (2001) Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglucose (FDG). Nucl Med Commun 22(7):747-753
8. Ogawa M, Ishino S, Mukai T et al (2004) (18)F-FDG accumulation in atherosclerotic plaques: Immunohistochemical and PET imaging study. J Nucl Med 45(7):1245-1250
9. Rudd JH, Warburton EA, Fryer TD et al (2002) Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 105(23):2708-2711
10. Davies JR, Rudd JH, Fryer TD et al (2005) Identification of culprit lesions after transient ischemic attack by combined 18F fluorodeoxy-glucose positron-emission tomography and high-resolution magnetic resonance imaging. Stroke 36(12):2642-2647
11. Tawakol A, Migrino RQ, Bashian GG et al (2006) In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 48(9):1818-1824
12. Tahara N, Kai H, Ishibashi M et al (2006) Simvastatin attenuates plaque inflammation: Evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 48(9):1825-1831
13. Ben-Haim S, Kupzov E, Tamir A et al (2004) Evaluation of 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET/CT. J Nucl Med 45(11):1816-1821
14. Dunphy MP, Freiman A, Larson SM et al (2005) Association of vascular 18F-FDG uptake with vascular calcification. J Nucl Med 46(8):1278-1284
15. Tahara N, Kai H, Yamagishi S et al (2007) Vascular inflammation evaluated by [18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome. J Am Coll Cardiol 49(14):1533-1539